| Literature DB >> 35370362 |
Dan Li1, Zipeng Zhou2, Jiachen Sun2, Xifan Mei2.
Abstract
The pandemic of the novel coronavirus disease 2019 (COVID-19) is continuously causing hazards for the world. Effective detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can relieve the impact, but various toxic chemicals are also released into the environment. Fluorescence sensors offer a facile analytical strategy. During fluorescence sensing, biological samples such as tissues and body fluids have autofluorescence, giving false-positive/negative results because of the interferences. Fluorescence near-infrared (NIR) nanosensors can be designed from low-toxic materials with insignificant background signals. Although this research is still in its infancy, further developments in this field have the potential for sustainable detection of SARS-CoV-2. Herein, we summarize the reported NIR fluorescent nanosensors with the potential to detect SARS-CoV-2. The green synthesis of NIR fluorescent nanomaterials, environmentally compatible sensing strategies, and possible methods to reduce the testing frequencies are discussed. Further optimization strategies for developing NIR fluorescent nanosensors to facilitate greener diagnostics of SARS-CoV-2 for pandemic control are proposed.Entities:
Keywords: 5 G, the fifth generation technology standard for broadband cellular networks; ACE2, Angiotensin-converting enzyme 2; AIE, aggregation-induced emission; AIE810NP, an aggregation-induced emission (AIE) nanoparticle (λem = 810 nm); AIEgens, AIE luminogens; ASOs, antisense oligonucleotides; AuNP, Gold nanoparticle; CF647, a cyanine-based far-red fluorescent dye; COVID-19, The pandemic of the novel coronavirus disease 2019; CP-MNB, capture probe-conjugated magnetic bead particle; CdS, core/shell lead sulfide/cadmium sulfide; CoPhMoRe, corona phase molecular recognition; Cy7Cl, a cationic cyanine dye; DCNPs, Down-conversion nanoparticles; DPV, Differential pulse voltammetry; DSNP, down shifting nanoparticles; DSNP@MY-1057-GPC-3, active targeting antibody glypican-3 (GPC-3) was conjugated with DSNP@MY-1057; E, envelope; EB-NS, prepared by the layered pigment CaCuSi4O10 (Egyptian Blue, EB) via ball milling and facile tip sonication into NIR fluorescent nanosheets; ENMs, electrospun nanofibrous membranes; Environmental-friendly; FLU, an infectious disease caused by influenza viruses; FRET, fluorescence resonance energy transfer; Green synthesis; HA1, hemagglutinin subunit.; HA1., hemagglutinin subunit; HAS, serum albumin; HCC, hepatocellular carcinoma; IONPs, iron oxide nanoparticles.; IONPs., iron oxide nanoparticles; IgG A, IgG aggregation; IgG, immunoglobulin G; IgM, immunoglobulin M; LED, light emitting diode; LICOR, IRDye-800CW; Low-toxic; M, membrane; MCU, microcontroller unit; MERS, Middle East respiratory syndrome coronavirus; N protein, nucleocapsid protein; N, nucleocapsid; NIR; NIR, Near-Infrared; NIR775, an H2S-inert fluorophore; Nanosensor; P, FITC-labelled GzmB substrate peptides; PBS, Phosphate-buffered saline; PCR, Polymerase Chain Reaction; PEG, branched by Polyethylene glycol; PEG1000 PE, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)− 1000]; PEG2000 PE, (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)− 2000);; POC, point-of-care; PS, polystyrene; Pb-Ag2S ODs, lead doped Ag2S quantum dots; QDs, quantum dots; QY, quantum yield; R, R represents a common recognition element for the target; RCA, rolling circle amplification; RNA, ribonucleic acid; S RBD, SARS-CoV-2 spike receptor-binding domain; S protein, spike protein; S, spike; SAM, self-assembled monolayer; SARS-CoV-2; SARS-CoV-2, Severe acute respiratory syndrome coronavirus; SPNs, semiconducting polymer nanoparticles.; SPNs., semiconducting polymer nanoparticles; SWCNTs, single-walled carbon nanotubes; Si-RP, silica-reporter probe; VIS, visible; VTM, viral transport medium; pGOLD, plasmonic gold
Year: 2022 PMID: 35370362 PMCID: PMC8964475 DOI: 10.1016/j.snb.2022.131764
Source DB: PubMed Journal: Sens Actuators B Chem ISSN: 0925-4005 Impact factor: 9.221
Fig. 1a, a scheme for the extraction and analysis of SARS-CoV-2 RNA from clinical samples using the electrochemical biosensors with RCA of the N and S genes. b, The electrochemical analysis by using a portable potentiostat device connected to a laptop. Note: The N gene is the nucleocapsid protein for RNA packaging and viral particle release.
Fig. 2A promising platform for in-vivo sensing of SARS-CoV-2 using NIR fluorescent nanosensor based on the employment of NIR fluorescent nanomaterials with environmental-friendly properties.
Examples of the NIR fluorescent nanosensors for the detection of various analytes.
| Sensors | Chromophores | Main hazard release | Analysis target | Readout | Ref. |
|---|---|---|---|---|---|
| SWCNTs-R | SWCNTs | The organic reagents during the production | Bacteria; Serotonin; H2O2; IgG A; Cytometry; metal ions, etc. | 900–1250 nm | |
| EB-NS-R | EB-NS | The release of Cu2+ | Potential bioimaging for various analytes | 910 nm | |
| Pb-Ag2S ODs-R | Pb-Ag2S ODs | The release of Pb2+ | H2O2 | 1200 nm | |
| SPNs-R | SPNs | The ogrianic reagents during the production | Cancer | 1300–1400 nm | |
SWCNTs, single-walled carbon nanotubes; SWCNTs-R, SWCNTs in combination with a receptor (R); R in sensors represent the corresponding receptors; IgG A, IgG aggregation; NIR775, an H2S-inert fluorophore; Cy7Cl, a cationic cyanine dye; HyNPs, hybrid micellar nanoparticles; NPs, nanoparticles; FRET, fluorescence resonance energy transfer; IONPs, iron oxide NPs; P, FITC-labelled GzmB substrate peptides; LICOR, IRDye-800CW; EB-NS, prepared by the layered pigment CaCuSi4O10 (Egyptian Blue, EB) via ball milling and facile tip sonication into NIR fluorescent nanosheets; DSNP@MY-1057-GPC-3, active targeting antibody glypican-3 (GPC-3) was conjugated with DSNP@MY-1057; MY-1057, a common cyanine dye; HCC, hepatocellular carcinoma; DSNP, lanthanide downshifting NPs (DSNPs): β-NaYF4 @NaYF4:1%Nd; Pb-Ag2S ODs, lead doped Ag2S quantum dots; SPNs, semiconducting polymer NPs.
Fig. 3(a) The conjugation of thiolated ASO with the oleic acid capped Pbs QDs. Imaging of the lung tissues (b) in the absence and (c) presence of SARS-CoV-2 viral RNA while injected with PbS QD-ASO; i and iv are the bright-field images; ii and v show the auto-fluorescence from the biological tissues; iii and vi present NIR-II imaging of the tissues; (d) TEM image of the sensor in the absence (up) and the presence of SARS-CoV-2 (down).
Fig. 4The selectivity and sensitivity of ACE2-SWCNT NIR fluorescent nanosensor. (a) Normalized fluorescence (ΔF/F0) change of the 1130 nm SWCNT emission peak for the ACE2- SWCNT nanosensor at 0 and 90 min after exposure to 10 mg/L of viral protein panel shows the sensor has a selectivity of SARS-CoV-2 S RBD against other samples in Phosphate-buffered saline (PBS) solutions: SARS-CoV-2 spike RBD (S RBD), SARS-CoV-1 S RBD, MERS S RBD, and FLU (FLU refers to an infectious disease caused by influenza viruses) HA1. (b) The sensor response at 90 min after exposure to 1 μM S RBD in the presence of 1% relevant biofluids is not selective: viral transport medium (VTM), saliva, nasal fluid, and sputum. (c) The biofouling of the NIR nanosensor with proteins present in relevant biofluids, mitigated by passivation using a PE-PEG polymer (phosphatidylethanolamine phospholipid with a 5000 Da PEG chain).
Fig. 5a, Operation progress. The gate electrode is exposed to the mixture of the sample and binding buffer (1), washed by PBS (2), OECT signal acquisition (3). b, The construction of gate functionalization layers. The biological self-assembled monolayer (SAM) (Bio-SAMs) and a combined chemical SAM (Chem-SAMs) on the gate electrode surface. c, Molecular architecture of the nanobody recognization system: The chem-SAM is formed by SpyTag peptide that is coupled to the HDT monolayer; The nanobody–SpyCatcher fusion protein attaches to this layer through the autocatalytic formation of a covalent SpyCatcher–SpyTag bond.
Fig. 6(a) PEG-phospholipid library for CoPhMoRe-based SWCNT nanosensors. (b) Scheme for CoPhMoRe system to detect SARS-CoV‑2 proteins using PEG-phospholipid/SWCNT nanosensors on N and S viral proteins. (c) Screening results of the integrated normalized response of nanosensors library on N protein (top) and S protein (bottom). Dashed lines indicate the best nanosensor for each protein. nanosensor ii and nanosensor vi showed the most remarkable fluorescence decreases in 50–70%, indicating these two sensors have optimized polymer receptors.
Fig. 7(a) Synthesis and conjugation of AIE810NP with SARS-CoV-2 antigen and chicken immunoglobulin Y (IgY). (b) A lateral-flow test strip was fabricated for the detection of IgM and IgG. (c) The portable reader contains a 680 nm LED lamp (excitation), a complementary metal-oxide-semiconductor (CMOS) camera, and a set of optics. (d) Scheme for different test results: coexistence of M line, G line, and C line indicate IgM/IgG positive; both M line and C line appear, which mean IgM positive; coexistence of G line and C line represent IgG positive; The presence of C line only shows IgM/IgG negative; No line reveals an invalid test strip.
Fig. 8In vivo detection of SARS-CoV-2 Mpro by renal-clearable NIR fluorescent sensors. The peptide substrate of SARS-CyCD was specifically cleaved by Mpro, activating NIRF signal and liberating the renal-clearable fluorescent fragment (SARS-CyCD).
Fig. 9(a) The UCNPs based lateral flow assay in detection of SARS-CoV-2. (b) A proposed 5 G-enabled VIS fluorescence sensor. (c) The circuit and hardware of the proposed sensor. The 5 G-enabled VIS fluorescence sensor includes a focusing lens, a high-speed camera, a 980 nm wavelength optical filter, a motor driver, a 980 nm light-emitting diode (LED) module, a Bluetooth model, and a microcontroller unit (MCU) pre-embedded with control and processing modules. The images captured by the camera could be grayed out and de-contextualized by the data processing module. The obtained T/C value is used to determine the concentration of the virus.
Promising nanomaterials for designing NIR fluorescent sensors of SARS-CoV-2.
| NPs | Excitation | Emission | QY | Production | Possible pollutants | Previous applications | Ref. |
|---|---|---|---|---|---|---|---|
| SWCNTS | 808 nm | 1500–1700 nm | 0.01% | Laser vaporization synthesis; DSPEmPEG(5k) functionalization | Susfactants | In vivo imaging | |
| SWCNTS | 561 nm | 990 nm, 1130 nm | 0.6–1.3% | CoMoCAT® process | Susfactants | Biosensing | |
| Rare earth based DCNPs | 980 nm | > 1500 nm | 0.27%− 0.73 | Solvent Thermal/Hydrothermal; Functionalization | Organic solvent | Biological imaging | |
| Rare earth based DCNPs | 808 nm | 1000–1700 nm | Not mentioned | Solvent Thermal/Hydrothermal; Functionalization | Organic solvent | Tumor biomarker imaging | |
| Rare earth UCNPs | 980 nm | 800 nm | ∼ 7.9% | Sovent Thermal/Hydrothermal; Functionalization | Organic solvent | Lateral flow detection of avian influenza virus | |
| Inorganic Nanoshells | 808 nm | 1064 nm | Not mentioned | Sonochemical | Functionalized agents | Cancer therapy | |
| Polymers | 1064 nm | 940 nm | Not mentioned | Emulsions method; Functionalizaiton | Organic solvent | PTT; Photoacoustic imaging | |
| Semiconductor QDs | 808 nm | 1039–1600 nm | 2.2–22% | Organic phase synthesis; Functionalization | Organic solvent | Fluorescence imaging | |
| CDs | 808 nm | 900–1200 nm | 0.4% | Hydrothermal synthesis | None | PTT | |
| AuNCs | 808 nm | 1050 nm | 0.11%− 0.27% | Green aquesous synthesis | None | Tumour or bone targeted imaging | |
| AIE NPs | 793 nm | 1030–1600 nm | 11.5% | Nanoprecipitation method | Organic solvent | Blood vessel imaging |
Note: Down-conversion NPs, DCNPs; PEG-CSQDs, core/shell lead sulfide/cadmium sulfide (CdS) quantum dots (CSQDs) branched by Polyethylene glycol (PEG); AuNCs, gold nanoclusters; AIE NPs, NPs with aggregation-induced emission; PTT, photothermal therapy; CDs, carbon dots; AuNCs, gold nanoclusters.